StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Lokelma (sodium zirconium cyclosilicate) by Quarter

Lokelma (sodium zirconium cyclosilicate) — Worldwide product sales ($M) ($M)

QuarterlyAnnual

AstraZeneca Lokelma (sodium zirconium cyclosilicate): $221M in Q2 2026, up 26.3% from a year earlier. That is the highest of the 29 quarters on record here.

Latest, Q2 2026
221
Period ended Jun 30, 2026
Change on a year earlier
+26.3%
175 in Q2 2025
History
29 quarters
Since Q2 2019
Sources
25
Documents cited below

Where the Q2 2026 figure comes from

“|| Lokelma | 221 | | 26 | | 26 | | 85 | | 13 | | 48 | | 47 | | 40 | | 47 | | 54 | | 46 | | 41 | | 12 | | 22”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K Quarterly & Form 20-F Product Sales by Medicine & Region Tables.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLokelma (sodium zirconium cyclosilicate) — Worldwide product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026221+26.3%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026199+30.1%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025181+20.7%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025189+32.2%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025175+28.7%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025153+34.2%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024150+33.9%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024143+40.2%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024136+36.0%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024114+16.3%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023112+38.3%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023102+29.1%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023100+51.5%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 202398+55.6%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 202281+50.0%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 202279+61.2%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up lokelma (sodium zirconium cyclosilicate)

Cite this data

StockData. (2026). AstraZeneca Lokelma (sodium zirconium cyclosilicate) ($M), quarterly Q2 2019–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-lokelma-world

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.

See a number that looks wrong?